SUMMARY Angiotensinogen is the most important component of the renin-angiotensin system present in the cerebrospinal fluid (CSF) of the rat. Its physiological significance as well as its origin have not been clearly elucidated. In this experiment we have examined plasma renin activity (PRA) and plasma and CSF angiotensinogen concentration under the following experimental conditions in male rats of the Wistar strain: 1) adrenalectomy (Adx) 4 days prior to sample collection; controls were sham Adx animals; 2) nephrectomy (Nx) 48 hours before blood and CSF collection; controls were sham Nx rats; 3) DOC-salt treatment (Cortexon depot, 50 mg/kg.s.c. twice a week) plus saline to drink was given during 4 weeks; controls were intact rats; 4) DOC-salt plus captopril: captopril (100 mg/kg/ day) in the drinking fluid was added to the treatment of experimental and control animals of Group 3; 5) two-kidney, two clip hypertension: silver clips placed in both renal arteries 8 weeks before samples collection; control: sham-operated rats; 6) water deprivation: rats deprived of water for 5 days; controls: intact rats; 7) peripheral sympathectomy: 6-hydroxydopamine (6-HODA) injected s.c. from birth until 16 weeks of age, adrenodemedullectomy and adrenal denervation performed at 8 weeks; controls were vehicle-injected animals.Determination of angiotensinogen concentration in plasma and CSF was accomplished by incubation of the samples with excess hog renin. The angiotensin I released as well as PRA were evaluated using an specific radioimmunoassay technique. PRA was significantly increased by Adx, captopril treatment, and water deprivation, and was almost suppressed by Nx, DOC-salt, and DOC-salt plus captopril treatment. Plasma angiotensinogen concentration was significantly elevated by Nx and significantly diminished by Adx, DOC-salt, and DOC-salt plus captopril, and captopril treatment. T HE presence of angiotensinogen in the brain and cerebrospinal fluid (CFS) of rabbits, dogs, rats, and humans has been clearly demonstrated. '^ Biochemical analysis has shown a similar molecular weight and electrophoretic mobility for plasma and CSF renin substrate; moreover, the final product released by both prohormones was identical to synthetic angiotensin I (AI) with respect to isoelectric point or pressor response.3 Clear differences between CSF and plasma angiotensinogen were also observed. In this regard, central renin substrate was heterogeneous with respect to isoionic points; the plasma protein presented only one component. In addition, im- munological differences between the central and peripheral renin substrate were also established.5 Although not definitively demonstrated, most of the available information supports a central origin for the angiotensinogen present in the brain and CSF of mammals and humans. Some experimental conditions determine a similar change in peripheral and central prohormone. 6 However, in a previous report 7 we found a clear dissociation between plasma and brain angiotensinogen in DOC-salt-treated hypertensi...